nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.469	1	CiPCiCtD
Medrysone—NR3C1—prostate cancer	0.173	1	CbGaD
Medrysone—Testosterone—Abiraterone—prostate cancer	0.0664	0.222	CrCrCtD
Medrysone—Drostanolone—Estradiol—prostate cancer	0.0409	0.137	CrCrCtD
Medrysone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0374	0.125	CrCrCtD
Medrysone—Testosterone—Estramustine—prostate cancer	0.0276	0.0922	CrCrCtD
Medrysone—NR3C1—Prednisone—prostate cancer	0.0233	1	CbGbCtD
Medrysone—Testosterone—Estrone—prostate cancer	0.0219	0.0733	CrCrCtD
Medrysone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0182	0.0609	CrCrCtD
Medrysone—Testosterone—Estradiol—prostate cancer	0.0166	0.0555	CrCrCtD
Medrysone—Hydrocortamate—Prednisone—prostate cancer	0.00779	0.0261	CrCrCtD
Medrysone—Cortisone acetate—Prednisone—prostate cancer	0.00755	0.0252	CrCrCtD
Medrysone—Fluocortolone—Prednisone—prostate cancer	0.00711	0.0238	CrCrCtD
Medrysone—Paramethasone—Prednisone—prostate cancer	0.00639	0.0214	CrCrCtD
Medrysone—Methyltestosterone—Prednisone—prostate cancer	0.00639	0.0214	CrCrCtD
Medrysone—Fluorometholone—Prednisone—prostate cancer	0.00609	0.0204	CrCrCtD
Medrysone—Loteprednol—Prednisone—prostate cancer	0.00609	0.0204	CrCrCtD
Medrysone—Rimexolone—Prednisone—prostate cancer	0.00595	0.0199	CrCrCtD
Medrysone—Methylprednisolone—Prednisone—prostate cancer	0.00569	0.019	CrCrCtD
Medrysone—Prednisolone—Prednisone—prostate cancer	0.00557	0.0186	CrCrCtD
Medrysone—Hydrocortisone—Prednisone—prostate cancer	0.00535	0.0179	CrCrCtD
Medrysone—Sensation of foreign body—Ethinyl Estradiol—prostate cancer	0.0014	0.0807	CcSEcCtD
Medrysone—Eye infection—Estradiol—prostate cancer	0.000959	0.0553	CcSEcCtD
Medrysone—NR3C1—urine—prostate cancer	0.000783	0.26	CbGeAlD
Medrysone—Nerve injury—Prednisone—prostate cancer	0.000756	0.0436	CcSEcCtD
Medrysone—Ulcerative keratitis—Prednisone—prostate cancer	0.000654	0.0377	CcSEcCtD
Medrysone—Cataract subcapsular—Prednisone—prostate cancer	0.000633	0.0365	CcSEcCtD
Medrysone—Visual disturbance—Nilutamide—prostate cancer	0.000572	0.033	CcSEcCtD
Medrysone—Visual disturbance—Estradiol valerate/Dienogest—prostate cancer	0.000538	0.031	CcSEcCtD
Medrysone—SERPINA6—renal system—prostate cancer	0.000437	0.145	CbGeAlD
Medrysone—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.000422	0.0364	CbGpPWpGaD
Medrysone—Impaired healing—Prednisone—prostate cancer	0.000382	0.022	CcSEcCtD
Medrysone—Visual impairment—Nilutamide—prostate cancer	0.000361	0.0209	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.000359	0.031	CbGpPWpGaD
Medrysone—Visual disturbance—Ethinyl Estradiol—prostate cancer	0.000349	0.0201	CcSEcCtD
Medrysone—Eye irritation—Estradiol—prostate cancer	0.000348	0.0201	CcSEcCtD
Medrysone—Finasteride—SRD5A2—prostate cancer	0.000348	0.106	CrCbGaD
Medrysone—Conjunctivitis—Cabazitaxel—prostate cancer	0.000342	0.0197	CcSEcCtD
Medrysone—Visual impairment—Estradiol valerate/Dienogest—prostate cancer	0.00034	0.0196	CcSEcCtD
Medrysone—SERPINA6—bone marrow—prostate cancer	0.000331	0.11	CbGeAlD
Medrysone—Viral infection—Estradiol—prostate cancer	0.000329	0.019	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.000316	0.0273	CbGpPWpGaD
Medrysone—Viral infection—Mitoxantrone—prostate cancer	0.000307	0.0177	CcSEcCtD
Medrysone—Conjunctivitis—Bicalutamide—prostate cancer	0.000293	0.0169	CcSEcCtD
Medrysone—Keratitis—Capecitabine—prostate cancer	0.000286	0.0165	CcSEcCtD
Medrysone—Visual disturbance—Conjugated Estrogens—prostate cancer	0.000285	0.0164	CcSEcCtD
Medrysone—NR3C1—prostate gland—prostate cancer	0.000281	0.0932	CbGeAlD
Medrysone—Vision blurred—Degarelix—prostate cancer	0.000275	0.0159	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000272	0.0235	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000272	0.0235	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000272	0.0235	CbGpPWpGaD
Medrysone—Finasteride—SRD5A1—prostate cancer	0.000264	0.0802	CrCbGaD
Medrysone—Visual impairment—Bicalutamide—prostate cancer	0.000261	0.0151	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000257	0.0222	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000256	0.0221	CbGpPWpGaD
Medrysone—Pain—Estrone—prostate cancer	0.000245	0.0142	CcSEcCtD
Medrysone—NR3C1—seminal vesicle—prostate cancer	0.000238	0.0789	CbGeAlD
Medrysone—Pain—Nilutamide—prostate cancer	0.000228	0.0131	CcSEcCtD
Medrysone—Visual disturbance—Estradiol—prostate cancer	0.000228	0.0131	CcSEcCtD
Medrysone—Eye irritation—Docetaxel—prostate cancer	0.000224	0.0129	CcSEcCtD
Medrysone—Visual impairment—Ethinyl Estradiol—prostate cancer	0.000221	0.0127	CcSEcCtD
Medrysone—Glaucoma—Prednisone—prostate cancer	0.000219	0.0127	CcSEcCtD
Medrysone—Eye irritation—Capecitabine—prostate cancer	0.000217	0.0125	CcSEcCtD
Medrysone—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000214	0.0124	CcSEcCtD
Medrysone—NR3C1—epithelium—prostate cancer	0.000206	0.0685	CbGeAlD
Medrysone—Pain—Degarelix—prostate cancer	0.000204	0.0117	CcSEcCtD
Medrysone—Keratitis—Epirubicin—prostate cancer	0.000199	0.0115	CcSEcCtD
Medrysone—Pain—Cabazitaxel—prostate cancer	0.000192	0.0111	CcSEcCtD
Medrysone—NR3C1—renal system—prostate cancer	0.000192	0.0636	CbGeAlD
Medrysone—NR3C1—urethra—prostate cancer	0.000188	0.0624	CbGeAlD
Medrysone—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000184	0.0106	CcSEcCtD
Medrysone—Keratitis—Doxorubicin—prostate cancer	0.000184	0.0106	CcSEcCtD
Medrysone—Viral infection—Prednisone—prostate cancer	0.000183	0.0106	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000182	0.0157	CbGpPWpGaD
Medrysone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000181	0.0156	CbGpPWpGaD
Medrysone—Visual impairment—Conjugated Estrogens—prostate cancer	0.00018	0.0104	CcSEcCtD
Medrysone—Hypersensitivity—Degarelix—prostate cancer	0.000175	0.0101	CcSEcCtD
Medrysone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.00017	0.0517	CrCbGaD
Medrysone—Hypersensitivity—Cabazitaxel—prostate cancer	0.000165	0.00953	CcSEcCtD
Medrysone—Pain—Bicalutamide—prostate cancer	0.000164	0.00949	CcSEcCtD
Medrysone—Conjunctivitis—Estradiol—prostate cancer	0.000162	0.00933	CcSEcCtD
Medrysone—Stinging—Epirubicin—prostate cancer	0.000159	0.0092	CcSEcCtD
Medrysone—Vision blurred—Goserelin—prostate cancer	0.000155	0.00892	CcSEcCtD
Medrysone—Vision blurred—Conjugated Estrogens—prostate cancer	0.000153	0.00883	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.000151	0.0131	CbGpPWpGaD
Medrysone—Conjunctivitis—Mitoxantrone—prostate cancer	0.000151	0.00869	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.00015	0.013	CbGpPWpGaD
Medrysone—Stinging—Doxorubicin—prostate cancer	0.000148	0.00851	CcSEcCtD
Medrysone—Visual disturbance—Docetaxel—prostate cancer	0.000147	0.00846	CcSEcCtD
Medrysone—NR3C1—bone marrow—prostate cancer	0.000145	0.0481	CbGeAlD
Medrysone—Visual impairment—Estradiol—prostate cancer	0.000144	0.0083	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.000144	0.0124	CbGpPWpGaD
Medrysone—Viral infection—Epirubicin—prostate cancer	0.000143	0.00825	CcSEcCtD
Medrysone—Hypersensitivity—Bicalutamide—prostate cancer	0.000142	0.00818	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000133	0.0115	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000133	0.0115	CbGpPWpGaD
Medrysone—Viral infection—Doxorubicin—prostate cancer	0.000132	0.00763	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000132	0.0114	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	0.000125	0.0108	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.000125	0.0108	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	0.000124	0.0107	CbGpPWpGaD
Medrysone—NR3C1—testis—prostate cancer	0.000124	0.0411	CbGeAlD
Medrysone—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00012	0.00691	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.00012	0.0103	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	0.000117	0.0101	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	0.000117	0.0101	CbGpPWpGaD
Medrysone—Pain—Goserelin—prostate cancer	0.000114	0.0066	CcSEcCtD
Medrysone—Vision blurred—Mitoxantrone—prostate cancer	0.000114	0.00659	CcSEcCtD
Medrysone—Pain—Conjugated Estrogens—prostate cancer	0.000113	0.00654	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—ID3—prostate cancer	0.000113	0.00974	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—ESR2—prostate cancer	0.000111	0.00957	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	0.000109	0.00942	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	0.000104	0.00901	CbGpPWpGaD
Medrysone—Conjunctivitis—Docetaxel—prostate cancer	0.000104	0.00601	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.000102	0.00882	CbGpPWpGaD
Medrysone—Drostanolone—SHBG—prostate cancer	0.000101	0.0307	CrCbGaD
Medrysone—Conjunctivitis—Capecitabine—prostate cancer	0.000101	0.00582	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	9.92e-05	0.00857	CbGpPWpGaD
Medrysone—Hypersensitivity—Goserelin—prostate cancer	9.86e-05	0.00569	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—AR—prostate cancer	9.79e-05	0.00846	CbGpPWpGaD
Medrysone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	9.79e-05	0.00846	CbGpPWpGaD
Medrysone—Hypersensitivity—Conjugated Estrogens—prostate cancer	9.77e-05	0.00563	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	9.73e-05	0.0084	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—RXRA—prostate cancer	9.71e-05	0.00839	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	9.47e-05	0.00818	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	9.43e-05	0.0286	CrCbGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	9.29e-05	0.00802	CbGpPWpGaD
Medrysone—Visual impairment—Docetaxel—prostate cancer	9.27e-05	0.00535	CcSEcCtD
Medrysone—Pain—Estradiol—prostate cancer	9.07e-05	0.00523	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—NCOA2—prostate cancer	9.02e-05	0.00779	CbGpPWpGaD
Medrysone—NR3C1—lymph node—prostate cancer	8.97e-05	0.0298	CbGeAlD
Medrysone—Visual impairment—Capecitabine—prostate cancer	8.97e-05	0.00518	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	8.97e-05	0.00775	CbGpPWpGaD
Medrysone—Testosterone Propionate—CYP17A1—prostate cancer	8.89e-05	0.027	CrCbGaD
Medrysone—Drostanolone—AR—prostate cancer	8.86e-05	0.0269	CrCbGaD
Medrysone—NR3C1—Nuclear Receptors—VDR—prostate cancer	8.8e-05	0.0076	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	8.76e-05	0.00757	CbGpPWpGaD
Medrysone—Hydrocortisone—ANXA1—prostate cancer	8.72e-05	0.0265	CrCbGaD
Medrysone—Testosterone—CYP3A43—prostate cancer	8.5e-05	0.0258	CrCbGaD
Medrysone—Pain—Mitoxantrone—prostate cancer	8.45e-05	0.00488	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	8.24e-05	0.00712	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	7.98e-05	0.00689	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	7.94e-05	0.00686	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—MIF—prostate cancer	7.89e-05	0.00681	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	7.83e-05	0.00676	CbGpPWpGaD
Medrysone—Hypersensitivity—Estradiol—prostate cancer	7.82e-05	0.00451	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	7.74e-05	0.00668	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	7.68e-05	0.00663	CbGpPWpGaD
Medrysone—Vision blurred—Capecitabine—prostate cancer	7.64e-05	0.00441	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—NCOA1—prostate cancer	7.6e-05	0.00656	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	7.58e-05	0.00655	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	7.51e-05	0.00648	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	7.5e-05	0.00648	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	7.49e-05	0.00647	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	7.44e-05	0.00643	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—PPARA—prostate cancer	7.42e-05	0.00641	CbGpPWpGaD
Medrysone—Drostanolone—CYP19A1—prostate cancer	7.41e-05	0.0225	CrCbGaD
Medrysone—Hypersensitivity—Mitoxantrone—prostate cancer	7.28e-05	0.0042	CcSEcCtD
Medrysone—Testosterone Propionate—COMT—prostate cancer	7.24e-05	0.022	CrCbGaD
Medrysone—NR3C1—Circadian Clock—RXRA—prostate cancer	7.23e-05	0.00624	CbGpPWpGaD
Medrysone—Finasteride—CYP3A5—prostate cancer	7.11e-05	0.0216	CrCbGaD
Medrysone—Pain—Etoposide—prostate cancer	7.03e-05	0.00406	CcSEcCtD
Medrysone—Conjunctivitis—Epirubicin—prostate cancer	7.02e-05	0.00405	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	6.95e-05	0.006	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	6.95e-05	0.006	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	6.84e-05	0.00591	CbGpPWpGaD
Medrysone—Vision blurred—Prednisone—prostate cancer	6.8e-05	0.00393	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—TH—prostate cancer	6.75e-05	0.00583	CbGpPWpGaD
Medrysone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	6.72e-05	0.00581	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—ESR1—prostate cancer	6.72e-05	0.00581	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	6.61e-05	0.00571	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	6.58e-05	0.00569	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	6.55e-05	0.00566	CbGpPWpGaD
Medrysone—Conjunctivitis—Doxorubicin—prostate cancer	6.5e-05	0.00375	CcSEcCtD
Medrysone—Drospirenone—AR—prostate cancer	6.44e-05	0.0196	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	6.36e-05	0.00549	CbGpPWpGaD
Medrysone—Visual impairment—Epirubicin—prostate cancer	6.25e-05	0.00361	CcSEcCtD
Medrysone—Loteprednol—NR3C1—prostate cancer	6.15e-05	0.0187	CrCbGaD
Medrysone—Hypersensitivity—Etoposide—prostate cancer	6.06e-05	0.00349	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	6.05e-05	0.00523	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	6.02e-05	0.0052	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—AHR—prostate cancer	5.92e-05	0.00512	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	5.86e-05	0.00506	CbGpPWpGaD
Medrysone—Pain—Docetaxel—prostate cancer	5.84e-05	0.00337	CcSEcCtD
Medrysone—Visual impairment—Doxorubicin—prostate cancer	5.78e-05	0.00334	CcSEcCtD
Medrysone—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	5.7e-05	0.00492	CbGpPWpGaD
Medrysone—Pain—Capecitabine—prostate cancer	5.66e-05	0.00326	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	5.64e-05	0.00487	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	5.6e-05	0.00484	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	5.57e-05	0.00481	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—PPARA—prostate cancer	5.52e-05	0.00477	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	5.52e-05	0.00477	CbGpPWpGaD
Medrysone—Flurandrenolide—NR3C1—prostate cancer	5.45e-05	0.0165	CrCbGaD
Medrysone—Testosterone Propionate—AR—prostate cancer	5.4e-05	0.0164	CrCbGaD
Medrysone—NR3C1—Circadian Clock—HIF1A—prostate cancer	5.37e-05	0.00463	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	5.35e-05	0.00462	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	5.34e-05	0.00462	CbGpPWpGaD
Medrysone—Vision blurred—Epirubicin—prostate cancer	5.32e-05	0.00307	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	5.31e-05	0.00459	CbGpPWpGaD
Medrysone—Hydrocortamate—NR3C1—prostate cancer	5.27e-05	0.016	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	5.25e-05	0.00453	CbGpPWpGaD
Medrysone—Cortisone acetate—NR3C1—prostate cancer	5.19e-05	0.0158	CrCbGaD
Medrysone—Hypersensitivity—Docetaxel—prostate cancer	5.03e-05	0.0029	CcSEcCtD
Medrysone—Megestrol acetate—NR3C1—prostate cancer	5e-05	0.0152	CrCbGaD
Medrysone—Vision blurred—Doxorubicin—prostate cancer	4.92e-05	0.00284	CcSEcCtD
Medrysone—Medroxyprogesterone Acetate—SHBG—prostate cancer	4.9e-05	0.0149	CrCbGaD
Medrysone—Hypersensitivity—Capecitabine—prostate cancer	4.87e-05	0.00281	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	4.8e-05	0.00415	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	4.67e-05	0.00404	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	4.67e-05	0.00403	CbGpPWpGaD
Medrysone—Methyltestosterone—SHBG—prostate cancer	4.61e-05	0.014	CrCbGaD
Medrysone—Rimexolone—NR3C1—prostate cancer	4.6e-05	0.014	CrCbGaD
Medrysone—NR3C1—Adipogenesis—NCOA2—prostate cancer	4.53e-05	0.00391	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	4.51e-05	0.0039	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	4.51e-05	0.00389	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	4.42e-05	0.00382	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—GADD45A—prostate cancer	4.39e-05	0.00379	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—CREBBP—prostate cancer	4.38e-05	0.00379	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	4.38e-05	0.00378	CbGpPWpGaD
Medrysone—Hypersensitivity—Prednisone—prostate cancer	4.34e-05	0.0025	CcSEcCtD
Medrysone—Medroxyprogesterone Acetate—AR—prostate cancer	4.29e-05	0.013	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	4.15e-05	0.00359	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	4.12e-05	0.00356	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—SERPINE1—prostate cancer	4.11e-05	0.00355	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	4.1e-05	0.00354	CbGpPWpGaD
Medrysone—Progesterone—CYP17A1—prostate cancer	4.08e-05	0.0124	CrCbGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	4.07e-05	0.00351	CbGpPWpGaD
Medrysone—Paramethasone—NR3C1—prostate cancer	4.06e-05	0.0123	CrCbGaD
Medrysone—Methyltestosterone—AR—prostate cancer	4.04e-05	0.0123	CrCbGaD
Medrysone—NR3C1—Endoderm Differentiation—APC—prostate cancer	3.99e-05	0.00345	CbGpPWpGaD
Medrysone—Fluorometholone—NR3C1—prostate cancer	3.96e-05	0.012	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	3.95e-05	0.00341	CbGpPWpGaD
Medrysone—Pain—Epirubicin—prostate cancer	3.94e-05	0.00227	CcSEcCtD
Medrysone—Progesterone—SLC22A3—prostate cancer	3.89e-05	0.0118	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	3.86e-05	0.00334	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	3.83e-05	0.00331	CbGpPWpGaD
Medrysone—Methylprednisolone—NR3C1—prostate cancer	3.83e-05	0.0116	CrCbGaD
Medrysone—NR3C1—Adipogenesis—NCOA1—prostate cancer	3.82e-05	0.0033	CbGpPWpGaD
Medrysone—Testosterone—SLC22A3—prostate cancer	3.68e-05	0.0112	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	3.67e-05	0.00317	CbGpPWpGaD
Medrysone—Pain—Doxorubicin—prostate cancer	3.65e-05	0.0021	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—RXRA—prostate cancer	3.63e-05	0.00314	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	3.58e-05	0.00309	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	3.57e-05	0.00309	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	3.56e-05	0.00307	CbGpPWpGaD
Medrysone—Prednisolone—CYP2A6—prostate cancer	3.5e-05	0.0106	CrCbGaD
Medrysone—Hydrocortisone—SHBG—prostate cancer	3.47e-05	0.0105	CrCbGaD
Medrysone—Hypersensitivity—Epirubicin—prostate cancer	3.4e-05	0.00196	CcSEcCtD
Medrysone—Methyltestosterone—CYP19A1—prostate cancer	3.38e-05	0.0103	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	3.35e-05	0.00289	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—ESR1—prostate cancer	3.31e-05	0.0101	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	3.3e-05	0.00285	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	3.22e-05	0.00278	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	3.19e-05	0.00275	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	3.18e-05	0.00275	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	3.16e-05	0.00273	CbGpPWpGaD
Medrysone—Hypersensitivity—Doxorubicin—prostate cancer	3.14e-05	0.00181	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—LPL—prostate cancer	3.14e-05	0.00271	CbGpPWpGaD
Medrysone—Finasteride—CYP3A4—prostate cancer	3.08e-05	0.00935	CrCbGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	3.07e-05	0.00266	CbGpPWpGaD
Medrysone—Hydrocortamate—CYP3A4—prostate cancer	3.05e-05	0.00928	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	3.02e-05	0.0026	CbGpPWpGaD
Medrysone—Cortisone acetate—CYP3A4—prostate cancer	3.01e-05	0.00913	CrCbGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	2.99e-05	0.00258	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—EP300—prostate cancer	2.99e-05	0.00258	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	2.91e-05	0.00885	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	2.87e-05	0.00248	CbGpPWpGaD
Medrysone—Progesterone—SHBG—prostate cancer	2.83e-05	0.00859	CrCbGaD
Medrysone—Progesterone—CYP1B1—prostate cancer	2.83e-05	0.00859	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	2.8e-05	0.00242	CbGpPWpGaD
Medrysone—Progesterone—SLC22A1—prostate cancer	2.79e-05	0.00848	CrCbGaD
Medrysone—NR3C1—Adipogenesis—PPARA—prostate cancer	2.77e-05	0.0024	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	2.76e-05	0.00239	CbGpPWpGaD
Medrysone—Hydrocortisone—CYP3A5—prostate cancer	2.76e-05	0.0084	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	2.74e-05	0.00237	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—BAZ2A—prostate cancer	2.74e-05	0.00237	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ZNF160—prostate cancer	2.74e-05	0.00237	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SSR2—prostate cancer	2.74e-05	0.00237	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	2.71e-05	0.00234	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	2.7e-05	0.00234	CbGpPWpGaD
Medrysone—Prednisolone—NR3C1—prostate cancer	2.7e-05	0.0082	CrCbGaD
Medrysone—NR3C1—Adipogenesis—HIF1A—prostate cancer	2.7e-05	0.00233	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	2.67e-05	0.00231	CbGpPWpGaD
Medrysone—Testosterone—SHBG—prostate cancer	2.67e-05	0.00812	CrCbGaD
Medrysone—Testosterone—CYP1B1—prostate cancer	2.67e-05	0.00812	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	2.65e-05	0.00229	CbGpPWpGaD
Medrysone—Testosterone—SLC22A1—prostate cancer	2.64e-05	0.00802	CrCbGaD
Medrysone—NR3C1—Adipogenesis—LEP—prostate cancer	2.63e-05	0.00227	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	2.6e-05	0.00224	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	2.58e-05	0.00223	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	2.53e-05	0.00218	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HNRNPH1—prostate cancer	2.51e-05	0.00217	CbGpPWpGaD
Medrysone—Progesterone—AR—prostate cancer	2.48e-05	0.00754	CrCbGaD
Medrysone—Drospirenone—PTGS2—prostate cancer	2.48e-05	0.00753	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	2.46e-05	0.00213	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.42e-05	0.00209	CbGpPWpGaD
Medrysone—Paramethasone—CYP3A4—prostate cancer	2.35e-05	0.00715	CrCbGaD
Medrysone—NR3C1—Adipogenesis—IRS1—prostate cancer	2.35e-05	0.00203	CbGpPWpGaD
Medrysone—Testosterone—AR—prostate cancer	2.34e-05	0.00712	CrCbGaD
Medrysone—NR3C1—Gene Expression—NFIC—prostate cancer	2.33e-05	0.00201	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.33e-05	0.00201	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.3e-05	0.00199	CbGpPWpGaD
Medrysone—Fluorometholone—CYP3A4—prostate cancer	2.3e-05	0.00698	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.28e-05	0.00197	CbGpPWpGaD
Medrysone—Progesterone—CYP3A5—prostate cancer	2.25e-05	0.00684	CrCbGaD
Medrysone—NR3C1—Adipogenesis—INS—prostate cancer	2.25e-05	0.00194	CbGpPWpGaD
Medrysone—Methylprednisolone—CYP3A4—prostate cancer	2.22e-05	0.00674	CrCbGaD
Medrysone—NR3C1—Gene Expression—RPN2—prostate cancer	2.19e-05	0.00189	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.19e-05	0.00189	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.19e-05	0.00189	CbGpPWpGaD
Medrysone—Progesterone—CYP2A6—prostate cancer	2.18e-05	0.00662	CrCbGaD
Medrysone—NR3C1—Adipogenesis—IGF1—prostate cancer	2.17e-05	0.00188	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.17e-05	0.00187	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.16e-05	0.00186	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.14e-05	0.00185	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.14e-05	0.00185	CbGpPWpGaD
Medrysone—Testosterone—CYP3A5—prostate cancer	2.13e-05	0.00647	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.11e-05	0.00182	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—QARS—prostate cancer	2.08e-05	0.00179	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.07e-05	0.00179	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.07e-05	0.00178	CbGpPWpGaD
Medrysone—Hydrocortisone—NR3C1—prostate cancer	2.06e-05	0.00627	CrCbGaD
Medrysone—Testosterone—CYP19A1—prostate cancer	1.96e-05	0.00596	CrCbGaD
Medrysone—Progesterone—ESR1—prostate cancer	1.91e-05	0.0058	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.91e-05	0.00165	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.9e-05	0.00164	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—TBX5—prostate cancer	1.9e-05	0.00164	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EIF3H—prostate cancer	1.77e-05	0.00153	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.76e-05	0.00152	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	1.69e-05	0.00513	CrCbGaD
Medrysone—Progesterone—NR3C1—prostate cancer	1.68e-05	0.00511	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.65e-05	0.00143	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.61e-05	0.00139	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.61e-05	0.00139	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.6e-05	0.00138	CbGpPWpGaD
Medrysone—Methyltestosterone—CYP3A4—prostate cancer	1.59e-05	0.00483	CrCbGaD
Medrysone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.58e-05	0.00136	CbGpPWpGaD
Medrysone—Prednisolone—CYP3A4—prostate cancer	1.56e-05	0.00475	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.55e-05	0.00134	CbGpPWpGaD
Medrysone—Progesterone—CYP2C19—prostate cancer	1.53e-05	0.00466	CrCbGaD
Medrysone—Progesterone—CYP1A1—prostate cancer	1.53e-05	0.00464	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.51e-05	0.00131	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.51e-05	0.00131	CbGpPWpGaD
Medrysone—Testosterone—CYP2C19—prostate cancer	1.45e-05	0.0044	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.45e-05	0.00125	CbGpPWpGaD
Medrysone—Testosterone—CYP1A1—prostate cancer	1.44e-05	0.00439	CrCbGaD
Medrysone—NR3C1—Gene Expression—TET2—prostate cancer	1.44e-05	0.00124	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MBD2—prostate cancer	1.44e-05	0.00124	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.42e-05	0.00123	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPL12—prostate cancer	1.41e-05	0.00122	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.41e-05	0.00121	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.39e-05	0.0012	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.39e-05	0.0012	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.34e-05	0.00115	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.33e-05	0.00115	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.32e-05	0.00114	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.31e-05	0.00113	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.3e-05	0.00113	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.3e-05	0.00112	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.3e-05	0.00112	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.23e-05	0.00106	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.2e-05	0.00104	CbGpPWpGaD
Medrysone—Hydrocortisone—CYP3A4—prostate cancer	1.2e-05	0.00364	CrCbGaD
Medrysone—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.09e-05	0.000943	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPL10—prostate cancer	1.07e-05	0.000925	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.05e-05	0.000908	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NPPA—prostate cancer	1.01e-05	0.000877	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.01e-05	0.000877	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.01e-05	0.000875	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MED12—prostate cancer	9.99e-06	0.000862	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—IL6—prostate cancer	9.83e-06	0.000849	CbGpPWpGaD
Medrysone—Progesterone—CYP3A4—prostate cancer	9.75e-06	0.00296	CrCbGaD
Medrysone—Testosterone—CYP3A4—prostate cancer	9.22e-06	0.0028	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	9.18e-06	0.000792	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	8.49e-06	0.000733	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RPS19—prostate cancer	8.49e-06	0.000733	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—DNMT1—prostate cancer	8.11e-06	0.000701	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	8.04e-06	0.000695	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOA2—prostate cancer	7.96e-06	0.000688	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—EZH2—prostate cancer	7.86e-06	0.000679	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PARP1—prostate cancer	7.69e-06	0.000664	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	7.54e-06	0.000651	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HSPA1A—prostate cancer	7.28e-06	0.000629	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ESR2—prostate cancer	7.28e-06	0.000629	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOA1—prostate cancer	6.71e-06	0.00058	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AR—prostate cancer	6.43e-06	0.000556	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—RXRA—prostate cancer	6.38e-06	0.000551	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SIRT1—prostate cancer	5.87e-06	0.000507	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—VDR—prostate cancer	5.78e-06	0.000499	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ERCC2—prostate cancer	5.29e-06	0.000457	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PPARA—prostate cancer	4.88e-06	0.000421	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	4.77e-06	0.000412	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—ESR1—prostate cancer	4.42e-06	0.000382	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—CREBBP—prostate cancer	3.87e-06	0.000334	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.63e-06	0.000314	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—MYC—prostate cancer	2.3e-06	0.000198	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AKT1—prostate cancer	1.59e-06	0.000138	CbGpPWpGaD
